“We use cookies on this website to enhance your user experience and to personalise content. By clicking any link or continuing to use our Website you agree to our cookies as per our Privacy Policy. Read More” Ok, I agree

Insulin Lispro (Humalog)

Trade Name : Humalog

Eli Lilly and Company

INJECTION, SOLUTION

Strength 100 [iU]/mL

INSULIN LISPRO Insulin [Chemical/Ingredient],Insulin Analog [EPC]

Delivery Process

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

We’ll Get in Touch

Once we review your request, we’ll send you an estimated price for the medicine within 2-5 days.

Confirmation and Payment

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Product information is meant for

Wholesalers Suppliers Exporters Doctors MOH Tender Supplies Hospitals Brand CROs Comparator Supplies Generic Cooperate Sourcing Individual Patients Indian Institutional Buyers

Disclaimer

Trade Marks displayed in compliance with provisions of: Trademark Act, 1999 u/s 30 and 30 (1) of "Fair use"

GNH India is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of Insulin Lispro (Humalog) which is also known as Humalog and Manufactured by Eli Lilly and Company. It is available in strength of 100 [iU]/mL per ml. Read more

Insulin Lispro (Humalog) is supplied for Tenders/ Emergency imports/ Un - licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials.  Click to know price.     Read less

Packaging and Delivery

Validated Cold Chain Shipment

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Inquire directly from our website and get 5% off on any medicine!

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more

About GNH

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more
  • No data
  • No data
  • HUMALOG is a rapid acting human insulin analog indicated to improve glycemic control in adults and children with diabetes mellitus.n
  • HUMALOG is a rapid acting human insulin analog indicated to improve glycemic control in adults and children with diabetes mellitus. ()n
  • No data
  • See Full Prescribing Information for important administration instructions. (, , , )n
  • Subcutaneous injection ():n
  • Continuous subcutaneous infusion (Insulin Pump) ():n
  • Intravenous Infusion ():n
  • The dosage of HUMALOG must be individualized based on the route of administration and the individual's metabolic needs, blood glucose monitoring results and glycemic control goal. ()n
  • Do not perform dose conversion when using the HUMALOG U-100 or U-200 prefilled pens. The dose window shows the number of insulin units to be delivered and no conversion is needed. (, )n
  • Do not mix HUMALOG U-200 with any other insulin. ()n
  • Injection: 100u00a0units per mL (U-100) clear and colorless solution available as:n
  • Injection: 200u00a0units per mL (U-200) clear and colorless solution available as:n
  • Injection: 100u00a0units/mL (U-100) is available as: ()n
  • Injection: 200u00a0units/mL (U-200) is available as: ()n
  • HUMALOG is contraindicated:n
  • Do not use during episodes of hypoglycemia. ()n
  • Do not use in patients with hypersensitivity to HUMALOG or any of its excipients. ()n
  • No data
  • Never share
  • Hyperglycemia or Hypoglycemia with Changes in Insulin Regimen:
  • Hypoglycemia:
  • Hypoglycemia Due to Medication Errors:
  • Hypersensitivity Reactions:
  • Hypokalemia:
  • Fluid Retention and Heart Failure with Concomitant Use of Thiazolidinediones (TZDs):
  • Hyperglycemia and Ketoacidosis Due to Insulin Pump Device Malfunction:
  • Adverse reactions associated with HUMALOG include hypoglycemia, allergic reactions, injection site reactions, lipodystrophy, pruritus, and rash. ()n
  • To report SUSPECTED ADVERSE REACTIONS, contact Eli Lilly and Company at 1-800-LillyRx (1-800-545-5979) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
  • No data
  • Drugs that Affect Glucose Metabolism:
  • Anti-Adrenergic Drugs (e.g., beta-blockers, clonidine, guanethidine, and reserpine):
  • Pediatrics:
  • 8.4
  • Excess insulin administration may cause hypoglycemia and hypokalemia. Mild episodes of hypoglycemia usually can be treated with oral glucose. Adjustments in drug dosage, meal patterns, or exercise may be needed. More severe episodes with coma, seizure, or neurologic impairment may be treated with intramuscular/subcutaneous glucagon or concentrated intravenous glucose. Sustained carbohydrate intake and observation may be necessary because hypoglycemia may recur after apparent clinical recovery. Hypokalemia must be corrected appropriately.n
  • Insulin lispro injection is a rapid-acting human insulin analog. Insulin lispro is produced by recombinant DNA technology utilizing a non-pathogenic laboratory strain of . Insulin lispro differs from human insulin in that the amino acid proline at position B28 is replaced by lysine and the lysine in position B29 is replaced by proline. Chemically, it is Lys(B28), Pro(B29) human insulin analog and has the empirical formula CHNOS and a molecular weight of 5808, both identical to that of human insulin.n
  • HUMALOG has the following primary structure:n
  • HUMALOG (insulin lispro injection) is a sterile, aqueous, clear, and colorless solution for subcutaneous or intravenous use. Each milliliter of HUMALOG U-100 contains 100u00a0units of insulin lispro, dibasic sodium phosphate (1.88u00a0mg), glycerin (16 mg), Metacresol (3.15u00a0mg), zinc oxide (content adjusted to provide 0.0197u00a0mg zinc ion), trace amounts of phenol, and Water for Injection, USP. Each milliliter of HUMALOG U-200 contains 200 units of insulin lispro, glycerin (16u00a0mg), Metacresol (3.15u00a0mg), tromethamine (5u00a0mg), zinc oxide (content adjusted to provide 0.046u00a0mg zinc ion), trace amounts of phenol, and Water for Injection, USP. Insulin lispro has a pH of 7.0 to 7.8.n
  • The pH is adjusted by addition of aqueous solutions of hydrochloric acid 10% and/or sodium hydroxide 10%.n
  • No data
  • No data
  • The safety and efficacy of HUMALOG U-100 were studied in children, adolescent, and adult patients with type 1 diabetes (n=789) and adult patients with type 2 diabetes (n=722).n
  • No data
  • Advise the patient to read the FDA-approved patient labeling
  • LOG-0006-PPI-20191115n
  • Instructions for Use
  • HUMALOGn- Arrayn- (HU-ma-log)n
  • Read this Instructions for Use before you start taking HUMALOG and each time you get a new vial. There may be new information. This information does not take the place of talking to your healthcare provider about your medical condition or your treatment.n
  • Do not share your needles or syringes with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.
  • Supplies needed to give your injection
  • Preparing your HUMALOG dose
  • If you use HUMALOG with NPH insulin:
  • Giving your HUMALOG Injection with a syringe
  • Giving your HUMALOG using an insulin pump
  • Disposing of used needles and syringes
  • How should I store HUMALOG?
  • All unopened vials:
  • After vials have been opened:
  • Keep HUMALOG vials, syringes, needles and all medicines out of the reach of children.
  • If you have any questions or problems with your HUMALOG, contact Lilly at 1-800-Lilly-Rx (1-800-545-5979) or call your healthcare provider for help. For more information on HUMALOG and insulin, go to www.humalog.com.n
  • Scan this code to launch the humalog.com websiten
  • This Instructions for Use has been approved by the U.S. Food and Drug Administration.n
  • Humalog is a registered trademark of Eli Lilly and Company.n
  • Revised: November 2019n
  • Marketed by: Lilly USA, LLC, Indianapolis, IN 46285, USA
  • Copyright u00a9 1996, 2019, Eli Lilly and Company. All rights reserved.n
  • LOGVL-0008-IFU-20191125n
  • Instructions for Use
  • HUMALOG KwikPenn- Array
  • insulin lispro injection
  • 100u00a0units/mL, 3u00a0mL single-patient-use pen
  • Read the Instructions for Use before you start taking HUMALOG and each time you get another KwikPen. There may be new information. This information does not take the place of talking to your healthcare provider about your medical condition or your treatment.n
  • Do not share your HUMALOG KwikPen with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.
  • HUMALOG KwikPen (u201cPenu201d) is a disposable single-patient-use prefilled pen containing 300u00a0units of HUMALOG. You can give yourself more than 1 dose from the Pen. Each turn (click) of the Dose Knob dials 1 unit of insulin. You can give from 1 to 60u00a0units in a single injection. The Plunger only moves a little with each injection, and you may not notice that it moves. The Plunger will only reach the end of the cartridge when you have used all 300u00a0units in the Pen.n
  • People who are blind or have vision problems should not use the Pen without help from a person trained to use the Pen.
  • How to recognize your HUMALOG KwikPen
  • Supplies you will need to give your injection
  • Preparing your Pen
  • Priming your Pen
  • Prime before each injection.
  • Selecting your dose
  • Giving your injection
  • After your injection
  • Disposing of Pens and Needles
  • Storing your Pen
  • Unused Pens
  • In-use Pen
  • General information about the safe and effective use of your Pen
  • Troubleshooting
  • If you have any questions or problems with your HUMALOG KwikPen, contact Lilly at 1-800-LillyRx (1-800-545-5979) or call your healthcare provider for help. For more information on HUMALOG KwikPen and insulin, go to www.humalog.com.n
  • Scan this code to launchn
  • www.humalog.comn
  • This Instructions for Use has been approved by the U.S. Food and Drug Administration.
  • HUMALOG and HUMALOG KwikPen are trademarks of Eli Lilly and Company.n
  • Revised: November 2019n
  • Marketed by: Lilly USA, LLCIndianapolis, IN 46285, USA
  • Copyright u00a9 2007, 2019, Eli Lilly and Company. All rights reserved.n
  • LOGKP-0007-IFU-20191115n
  • Instructions for Use
  • HUMALOGn- Arrayn- Junior KwikPenn- Array
  • insulin lispro injection
  • 100 units/mL, 3 mL single-patient-use pen
  • Read the Instructions for Use before you start taking HUMALOG and each time you get another HUMALOG Junior KwikPen. There may be new information. This information does not take the place of talking to your healthcare provider about your medical condition or your treatment.n
  • Do not share your HUMALOG Junior KwikPen with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.
  • HUMALOG Junior KwikPen (u201cPenu201d) is a disposable single-patient-use prefilled pen containing 300u00a0units of HUMALOG.n
  • People who are blind or have vision problems should not use the Pen without help from a person trained to use the Pen.
  • How to recognize your HUMALOG Junior KwikPen:
  • Supplies needed to give your injection:
  • Preparing your Pen
  • Priming your Pen
  • Prime before each injection.
  • Selecting your dose
  • Giving your injection
  • After your injection
  • Disposing of Pens and Needles
  • Storing your Pen
  • Unused Pens
  • In-use Pen
  • General information about the safe and effective use of your Pen
  • Troubleshooting
  • If you have any questions or problems with your HUMALOG Junior KwikPen, contact Lilly at 1-800-LillyRx (1-800-545-5979) or call your healthcare provider for help. For more information on HUMALOG Junior KwikPen and insulin, go to www.humalog.com.n
  • Scan this code to launchn
  • www.humalog.comn
  • This Instructions for Use has been approved by the U.S. Food and Drug Administration.
  • HUMALOG and HUMALOG Junior KwikPen are trademarks of Eli Lilly and Company.n
  • Revised: November 2019n
  • Marketed by: Lilly USA, LLC
  • Indianapolis, IN 46285, USA
  • Copyright u00a9 2017, 2019, Eli Lilly and Company. All rights reserved.n
  • LOGJRKP-0003-IFU-20191115n
  • Instructions for Use
  • HUMALOGn- Arrayn- Tempo Penu2122
  • insulin lispro injection
  • 100u00a0units/mL, 3u00a0mL pen, single-patient-use
  • Read the Instructions for Use before you start taking HUMALOG and each time you get another HUMALOG Tempo Pen. There may be new information. This information does not take the place of talking to your healthcare provider about your medical condition or your treatment.n
  • Do not share your HUMALOG Tempo Pen with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.
  • HUMALOG Tempo Pen (u201cPenu201d) is a disposable single-patient-use prefilled pen containing 300u00a0units of HUMALOG. You can give yourself more than 1 dose from the Pen. Each turn (click) of the Dose Knob dials 1 unit of insulin. You can give from 1 to 60u00a0units in a single injection. The Plunger only moves a little with each injection, and you may not notice that it moves. The Plunger will only reach the end of the cartridge when you have used all 300u00a0units in the Pen.n
  • People who are blind or have vision problems should not use the Pen without help from a person trained to use the Pen.
  • This HUMALOG Tempo Pen contains a component that allows for data connectivity when used with a compatible transmitter.n
  • How to recognize your HUMALOG Tempo Pen
  • Supplies you will need to give your injection
  • Preparing your Pen
  • Priming your Pen
  • Prime before each injection.
  • Selecting your dose
  • Giving your injection
  • After your injection
  • Disposing of Pens and Needles
  • Storing your Pen
  • Unopened Pens
  • In-use Pen
  • General information about the safe and effective use of your Pen
  • Troubleshooting
  • If you have any questions or problems with your HUMALOG Tempo Pen, contact Lilly at 1-800-LillyRx (1-800-545-5979) or call your healthcare provider for help. For more information on HUMALOG Tempo Pen and insulin, go to www.humalog.com.n
  • Scan this code to launchn
  • www.humalog.comn
  • This Instructions for Use has been approved by the U.S. Food and Drug Administration.n
  • HUMALOG is a registered trademark and TEMPO PEN is a trademark of Eli Lilly and Company.n
  • Issued: 11/2019n
  • Marketed by: Lilly USA, LLCIndianapolis, IN 46285, USA
  • Copyright u00a9 2019, Eli Lilly and Company. All rights reserved.n
  • LOGTP-0001-IFU-20191115n
  • LOG200-0003-PPI-20191115n
  • Instructions for Use
  • HUMALOG KwikPenn- Array
  • insulin lispro injection
  • 200u00a0units/mL, 3 mL single-patient-use pen
  • Read the Instructions for Use before you start taking HUMALOG and each time you get another KwikPen. There may be new information. This information does not take the place of talking to your healthcare provider about your medical condition or your treatment.n
  • Do not share your HUMALOG KwikPen with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.
  • HUMALOG KwikPen 200u00a0units/mL (u201cPenu201d) is a disposable single-patient-use prefilled pen containing 600u00a0units of HUMALOG. You can give yourself more than 1 dose from the Pen. Each turn (click) of the Dose Knob dials 1u00a0unit of insulin. You can give from 1 to 60u00a0units in a single injection. The Plunger only moves a little with each injection, and you may not notice that it moves. The Plunger will only reach the end of the cartridge when you have used all 600u00a0units in the Pen.n
  • HUMALOG KwikPen is available in 2 strengths, 100u00a0units/mL and 200u00a0units/mL. Inject HUMALOG 200u00a0units/mL only with your Pen. Do not transfer insulin from your Pen to a syringe. Syringes will not measure 200u00a0units/mL insulin correctly. A severe overdose can result, causing very low blood sugar which may put your life in danger.
  • People who are blind or have vision problems should not use the Pen without help from a person trained to use the Pen.
  • How to recognize your HUMALOG 200 units/mL KwikPen
  • Supplies needed to give your injection
  • Preparing your Pen
  • Priming your Pen
  • Prime before each injection.
  • Selecting your dose
  • This Pen has been made to deliver the dose that is shown in the Dose Window. Dial your usual dose as instructed by your healthcare provider.
  • Giving your injection
  • After your injection
  • Disposing of Pens and Needles
  • Storing your Pen
  • Unused Pens
  • In-use Pen
  • General information about the safe and effective use of your Pen
  • Troubleshooting
  • If you have any questions or problems with your HUMALOG KwikPen, contact Lilly at 1-800-LillyRx (1-800-545-5979) or call your healthcare provider for help. For more information on HUMALOG KwikPen and insulin, go to www.humalog.com.n
  • Scan this code to launchn
  • www.humalog.comn
  • This Instructions for Use has been approved by the U.S. Food and Drug Administration.
  • HUMALOG and HUMALOG KwikPen are trademarks of Eli Lilly and Company.n
  • Revised: November 2019n
  • Marketed by: Lilly USA, LLCIndianapolis, IN 46285, USA
  • Copyright u00a9 2015, 2019, Eli Lilly and Company. All rights reserved.n
  • LOGKP200-0004-IFU-20191115n
  • PACKAGE CARTON u2013 HUMALOG 10 mL vial
  • NDC 0002-7510-01n
  • 10 mLn
  • 100 units per mLn
  • Humalogn
  • insulin lispro injectionn
  • Rx onlyn
  • U-100n
  • www.humalog.comn
  • Lillyn
  • PACKAGE CARTON u2013 HUMALOG KwikPen
  • NDC 0002-8799-59n
  • Humalog KwikPenn
  • insulin lispro injectionn
  • For Single Patient Use Onlyn
  • Dispense in this sealed carton.n
  • U-100n
  • 100 units per mLn
  • Needles not includedn
  • This device is recommended for use with Becton, Dickinson and Company's insulin pen needlesn
  • prefilled insulin delivery devicen
  • Rx onlyn
  • 5 x 3 mL Prefilled Pensn
  • Read Insulin Delivery Device Instructions for Usen
  • PACKAGE CARTON u2013 HUMALOG Cartridge 3mL
  • NDC 0002-7516-59n
  • 100 units per mLn
  • VL-7516n
  • 5 x 3 mL Cartridgesn
  • Humalogn
  • insulin lispro injectionn
  • For Single Patient Use Onlyn
  • Rx onlyn
  • U-100n
  • For use in Eli Lilly and Company's HumaPen LUXURA HD insulin delivery device.n
  • www.humalog.comn
  • Lillyn
  • PACKAGE CARTON u2013 HUMALOG U200 KwikPen 2ct
  • Dispense in this sealed carton.n
  • NDC 0002-7712-27n
  • Humalog KwikPenu00aen
  • insulin lispro injectionn
  • For Single Patient Use Onlyn
  • 200 units per mL (U-200)n
  • prefilled insulin delivery devicen
  • 2 x 3 mL Prefilled Pensn
  • Rx onlyn
  • For subcutaneous use.n
  • Read Insulin Delivery Device Instructions for Use.n
  • NEEDLES NOT INCLUDEDn
  • This device is recommended for use with Becton, Dickinson and Company's insulin pen needles.n
  • PACKAGE CARTON u2013 HUMALOG Junior KwikPen
  • Dispense in this sealed carton.n
  • NDC 0002-7714-59n
  • Humalogn
  • Junior KwikPenn
  • insulin lispro injectionn
  • For Single Patient Use Onlyn
  • 100 units per mL (U-100)n
  • The pen can deliver 0.5 (u00bd) to 30 units in one injection.n
  • 5 x 3 mL prefilled pensn
  • prefilled insulin delivery devicen
  • Rx onlyn
  • Read Humalog Junior KwikPen Instructions for Use.n
  • NEEDLES NOT INCLUDEDn
  • This device is recommended for use with Becton, Dickinson and Company's insulin pen needles.n
  • Lillyn
  • PACKAGE CARTON u2013 HUMALOG Tempo Pen
  • NDC 0002-8213-05n
  • Humalogn
  • Tempo Penn
  • insulin lispro injectionn
  • For Single Patient Use Onlyn
  • HP-8213n
  • Dispense in this sealed carton.n
  • U-100n
  • 100 units per mLn
  • Needles not includedn
  • This device is recommended for use with Becton, Dickinson and Company's insulin pen needlesn
  • For subcutaneous use only.n
  • prefilled insulin delivery devicen
  • Rx onlyn
  • 5 x 3 mL Prefilled Pensn
  • Read Insulin Delivery Device Instructions for Usen

Similar Products

Desogestrel And Ethinyl Estradiol (Emoquette)

Desogestrel And Ethinyl Estradiol (Emoquette)

Manufacturer: REMEDYREPACK INC.

Presentation: KIT

Strength:

Pack Size:

Diphenoxylate Hydrochloride And Atropine Sulfate (Diphenoxylate Hydrochloride And Atropine Sulfate)

Diphenoxylate Hydrochloride And Atropine Sulfate (Diphenoxylate Hydrochloride And Atropine Sulfate)

Manufacturer: REMEDYREPACK INC.

Presentation: TABLET

Strength: 2.5; .025 mg/1; mg/1

Pack Size:

Fluoxetine Hydrochloride (Fluoxetine)

Fluoxetine Hydrochloride (Fluoxetine)

Manufacturer: REMEDYREPACK INC.

Presentation: CAPSULE

Strength: 40 mg/1

Pack Size:

Metoprolol Succinate (Metoprolol Succinate)

Metoprolol Succinate (Metoprolol Succinate)

Manufacturer: REMEDYREPACK INC.

Presentation: TABLET, EXTENDED RELEASE

Strength: 25 mg/1

Pack Size:

Losartan Potassium (Losartan Potassium)

Losartan Potassium (Losartan Potassium)

Manufacturer: REMEDYREPACK INC.

Presentation: TABLET, FILM COATED

Strength: 25 mg/1

Pack Size:

Browse Our Services And Processes

Comparator Sourcing for Clinical Trials

Comparator Sourcing for Clinical Trials

GNH India brings over 10 years of experience in Comparator

Read More

Name Patient Supply

Name Patient Supply

Today, the exact cause for many rare diseases remains unknown

Read More

Validated Cold Chain Shipment

Validated Cold Chain Shipment

With shifting of pharma industry from synthetic molecules to biologic

Read More

Clinical Trials Supply

Clinical Trials Supply

STOP SOURCING..... START SMART SOURCING...... COME STRAIGHT TO THE SOURCE

Read More

Pharmaceutical Contract Manufacturing

Pharmaceutical Contract Manufacturing

GNH Provides Contract Manufacturing services for: Generic Medicines with following

Read More

Pricing

Pricing

PRICING POLICY Terms of sales are typically prepaid, unless otherwise

Read More

Disclaimer

Please see the Legal Notice for detailed terms and disclaimers. The Legal Notice governs the use of this Website and by accessing and using this Website you agree to be bound by and accept the Legal Notice.

Browse from other international pharmaceuticals

General

64020 Products

GNH India Brings to over 64036 Product SKUs from India all at 1 place with easy access and global deliveries.

US NDC

71245 Products

GNH India Brings to over 71252 Product SKUs from India all at 1 place with easy access and global deliveries.

Canadian DIN

51046 Products

GNH India Brings to over 51047 Product SKUs from India all at 1 place with easy access and global deliveries.

Swiss Drugs

150 Products

GNH India Brings to over 150 Product SKUs from India all at 1 place with easy access and global deliveries.

NZ Drugs

13296 Products

GNH Brings to over 13298 Product SKUs from India all at 1 place with easy access and global deliveries.

FAQ

Check out our delivery process

Can’t find what
you’re looking for?

Contact US
Get Price

Are you an existing customer or a vendor of GNH India? Log in here to

View your Transaction
COMPANY
SERVICES
QUICK LINKS
CONTACT US
Registered Office Address:

Unit # G- 14, 15, 16, 17, Ground Floor, Prabhadevi Industrial Estate, Enterprises Industrial Premises, 408, Veer Sawarkar Road, Prabhadevi,
Mumbai 400025 India

US Office Address:

GNH Pharmaceuticals USA LLC,
Suite E # 499, 1235 EAST BLVD,
Charlotte, NC, 28203, U.S.A
TEL: +1 704 557 0412

Pharmexcil
DB
FIEO-2016
SiteLock

Copyright © 2024 GNHIndia .com. All Rights Reserved. Please read Legal Notice for further details.

Disclaimer: Product names, logos, brands and other trademarks featured or referred to are the property of their respective trademark holders.